Sol-gel announces positive top-line phase 3 trial results of twyneo

Sol-gel announces positive top-line phase 3 trial results of twyneo® for the treatment of acne vulgaris.sol gel technologies ltd - all co-primary endpoints achieved in both phase 3 clinical trials.sol gel technologies ltd - twyneo was well-tolerated and majority of local skin reactions, when reported, were mild and improved over time.sol gel technologies - there were no treatment-related serious adverse events in study.sol gel technologies - twyneo available to physicians & patients in second half of 2021.sol gel technologies - look forward to submitting nda for twyneo in h2 of 2020.sol gel technologies - 4 unrelated serious adverse events were reported across both phase 3 trials.
SLGL Ratings Summary
SLGL Quant Ranking